Further investigations are needed to address ZnT8 activity in triglyceride metabolism and to adopt ZnT8 as a useful gene target in studying precision nutrition or precision medicine for obesity and T2D prevention or treatments. The gene discussed is SLC30A8; the disease is obesity due to melanocortin 4 receptor deficiency.